🇺🇸 Ethinylestradiol / Dienogest in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abortion Induced — 1 report (10%)
2. Chest Pain — 1 report (10%)
3. Dyspnoea — 1 report (10%)
4. Foetal Exposure During Pregnancy — 1 report (10%)
5. Gastroschisis — 1 report (10%)
6. Herpes Zoster — 1 report (10%)
7. Maternal Exposure During Pregnancy — 1 report (10%)
8. Muscular Weakness — 1 report (10%)
9. Osteonecrosis — 1 report (10%)
10. Pneumonia — 1 report (10%)

Source database →

Frequently asked questions

Is Ethinylestradiol / Dienogest approved in United States?

Ethinylestradiol / Dienogest does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ethinylestradiol / Dienogest in United States?

University of Palermo is the originator. The local marketing authorisation holder may differ — check the official source linked above.